Home›Companies›Biotech & Pharma›Acta Pharmaceuticals

Acta Pharmaceuticals, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 22, 2024·Suggest an edit

About Acta Pharmaceuticals

Acta Pharmaceuticals is a private company based in Boston, Massachusetts, incorporated in 2022 in Delaware. It has reported $13,400,781 raised in one offering on Form D since April 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 29, 2023Apr 7, 2023amended Apr 22, 2024$13,400,781of $17.5M target29$462KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Acta Pharmaceuticals's Form D filed Apr 22, 2024.

GA
George Alex
President and director
TP
RT

Sources

  1. SECActa Pharmaceuticals, Inc. Form D, filed Apr 7, 2023
  2. SECActa Pharmaceuticals, Inc. filing history